References
1. Owens C, Toone T. A Survey of Dietary Supplement Knowledge, Attitudes, and Use in a Rural Population. J Nutr Food Sci. 2014;4(5).
2. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355(9198):134-8.
3. FDA. Drug Interactions: What You Should Know: U.S. Food and Drug Administration; 2013 [Available from: https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know.
4. Marcus DM, Grollman AP. Botanical medicines-the need for new regulations. N Engl J Med. 2002;347(25):2073-20176.
5. Henriksen K, Battles JB, Keyes MA, Grady ML. Risk of concurrent use of prescription drugs with herbal and dietary supplements in ambulatory care. Advances in Patient Safety: New Directions and Alternative Approaches. 2008;4(Technology and Medication Safety).
6. Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. The effect of grapefruit juice on drug disposition. Expert Opini Drug Met 2011;7(3):267-86.
7. Mannel M. Drug interactions with St John’s wort. Drug Safety. 2004;27(11):773-97.
8. Skinner CM. Preoperative use of herbal medicines: a patient survey. Br J Anaesth. 2002;89(5):792-5.
9. Mouly S, Lloret-Linares C, Sellier PO, Sene D, Bergmann JF. Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John’s Wort? Pharmacol Res. 2017;118:82-92.
10. Mutalik M, Sanghavi D. Review of drug interactions: A comprehensive update. J Pharm Res Int. 2014;4(8):954-80.
11. Chen M, Zhou SY, Fabriaga E, Zhang PH, Zhou Q. Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review. J Food Drug Anal. 2018;26(2S):S61-S71.
12. Wynia MK, Eisenberg DM, Wilson IB. Physician-patient communication about complementary and alternative medical therapies: a survey of physicians caring for patients with human immunodeficiency virus infection. J Altern Complement Med 1999;5(5):447-56.
13. Giveon SM, Liberman N, Klang S, Kahan E. A survey of primary care physicians’ perceptions of their patients’ use of complementary medicine. Complement Ther Med. 2003;11(4):254-60.
14. Winslow LC, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002;162(10):1176-81.
15. Wheaton AG, Blanck HM, Gizlice Z, Reyes M. Medicinal herb use in a population-based survey of adults: prevalence and frequency of use, reasons for use, and use among their children. Ann Epidemiol. 2005;15(9):678-85.
16. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology. 2002;11(3):212-20.
17. Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women’s views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006;6:40.
18. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the united states. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. 1998;280(18):1569-75.
19. Ndosi ME, Newell R. Nurses’ knowledge of pharmacology behind drugs they commonly administer. J Clin Nurs. 2009;18(4):570-80; discussion 620.
20. Benni JM, Jayanthi MK, Tubaki BR, Renuka M. Knowledge and awareness of food and drug interactions (FDI): a survey among health care professionals. International Journal of Pharmacology and Clinical Sciences. 2012;1(4):97-105.
21. Sajid S, Sultana R, Masaratunnisa M, Naaz S, Adil M. A questionnaire study of food – drug interactions to assess knowledge of people from diverse backgrounds. Asian J Med Health. 2017;5(2):1-9.
22. Kuo GM, Hawley ST, Weiss LT, Balkrishnan R, Volk RJ. Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complement Altern Med. 2004;4:18.
23. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann Nutr Metab. 2008;52 Suppl 1:29-32.
24. Sørensen JM. Herb–drug, food–drug, nutrient–drug, and drug–drug interactions: mechanisms involved and their medical implications. J Altern Complement Med. 2002;8(3):293-308.
25. Schmidt LE, Dalhoff K. Food Drug Interactions. Drugs. 2002;62(10):1481-502.
26. Singh JA, Bharat A, Edwards NL. An internet survey of common treatments used by patients with gout including cherry extract and juice and other dietary supplements. J Clin Rheumatol. 2015;21(4):225-6.
27. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ. 2004;328(7451):1312-5.
28. Marinac JS, Buchinger CL, Godfrey LA, Wooten JM, Sun C, Willsie SK. Herbal products and dietary supplements: a survey of use, attitudes, and knowledge among older adults. J Am Osteopath Assoc. 2007;107(1):13-23.
29. Department of Statistics. Population Estimates in Jordan 2019 [Available from: http://dosweb.dos.gov.jo/DataBank/Population_Estimares/PopulationEstimates.pdf.
30. Taherdoost H. Determining sample size; how to calculate survey sample size. Int J Econs & Mgmt. 2017;2:237-9.
31. Asahina Y, Hori S, Sawada Y. Community pharmacists’ attitudes relating to patients’ use of health products in Japan. Int J Clin Pharm. 2012;34(4):529-37.
32. Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J Ethnopharmacol. 2002;82(2-3):97-103.
33. Maregesi SM, Ngassapa OD, Pieters L, Vlietinck AJ. Ethnopharmacological survey of the Bunda district, Tanzania: plants used to treat infectious diseases. J Ethnopharmacol. 2007;113(3):457-70.
34. van Andel T, Westers P. Why Surinamese migrants in the Netherlands continue to use medicinal herbs from their home country. J Ethnopharmacol. 2010;127(3):694-701.
35. Kaur J, Kaur S, Mahajan A. Herbal medicines: possible risks and benefits. American Journal of Phytomedicine and Clinical Therapeutics. 2013;2:226-39.
36. Sahu PK, Giri DD, Singh R, Pandey P, Gupta S, Shrivastava AK, et al. Therapeutic and medicinal uses of Aloe vera: a review J Pharm Pharmacol. 2013;04(08):599-610.
37. Cortés-Rojas DF, de Souza CRF, Oliveira WP. Clove (Syzygium aromaticum): a precious spice. Asian Pac J Trop Biomed. 2014;4(2):90-6.
38. Lien HC, Sun WM, Chen YH, Kim H, Hasler W, Owyang C. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003;284(3):G481-G9.
39. Zaffani S, Cuzzolin L, Benoni G. Herbal products: behaviors and beliefs among Italian women. Pharmacoepidemiol Drug Saf. 2006;15(5):354-9.
40. Afifi FU, Abu-Irmaileh B. Herbal medicine in Jordan with special emphasis on less commonly used medicinal herbs. J Ethnopharmacol. 2000;72(1-2):101-10.
41. Abdelhalim A, Aburjai T, Hanrahan J, Abdel-Halim H. Medicinal plants used by traditional healers in Jordan, the Tafila region. Pharmacogn Mag. 2017;13(Suppl 1):S95–S101.
42. JFDA. Jordan National Drug Formulary: Jordan Food and Drug Administration; 2011 [Available from: http://www.jfda.jo/EchoBusV3.0/SystemAssets/PDF/AR/JNDF-Book/JNDF%20V2%202011.pdf.
43. van der Hoeven N, Visser I, Schene A, van den Born BJ. Severe hypertension related to caffeinated coffee and tranylcypromine: a case report. Ann Intern Med. 2014;160(9):657‐8.
44. van den Berg D, Zoellner KR, Ogunrombi MO, Malan SF, Terre’Blanche G, Castagnoli N, Jr., et al. Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues. Bioorg Med Chem. 2007;15(11):3692-702.
45. Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs. 1976;11(1):45-54.
46. Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride: effect of food, milk, and iron. J Am Acad Dermatol. 1985;12(2):308-12.
47. Jung H, Peregrina AA, Rodriguez JM, Moreno‐Esparza R. The influence of coffee with milk and tea with milk on the bioavailability of tetracycline. Biopharm Drug Dispos. 1997;18(5):459-63.
48. Opie LH. Drug interactions of antihypertensive agents. S Afr Fam Pract. 2014;54(2):S23-S5.
49. Burnakis TG, Mioduch HJ. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia. Arch Intern Med. 1984;144(12):2371-2.
50. Shionoiri H. Pharmacokinetic drug interactions with ACE inhibitors. Clin Pharmacokinet. 1993;25(1):20-58.
51. Hamann GL, Campbell JD, George CM. Warfarin-cranberry juice interaction. Ann Pharmacother. 2011;45(3):e17.
52. Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis. 2004;13(1):25-6.
53. Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ. 2003;327(7429):1454.
54. Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. Am J Ther. 2006;13(3):283-4.
55. Seden K, Dickinson L, Khoo S, Back D. Grapefruit-drug interactions. Drugs. 2010;70(18):2373-407.
56. Mertens-Talcott SU, Zadezensky I, De Castro WV, Derendorf H, Butterweck V. Grapefruit-drug interactions: can interactions with drugs be avoided? J Clin Pharmacol. 2006;46(12):1390-416.
57. Bailey DG, Dresser G, Arnold JMO. Grapefruit–medication interactions: Forbidden fruit or avoidable consequences? Can Med Assoc J. 2013;185(4):309-16.
58. Stump AL, Mayo T, Blum A. Management of grapefruit-drug interactions. Am Fam Physician. 2006;74(4):605-8.
59. Hijazi MA, Shatila H, El-Lakany A, Aboul Ela M, Kharroubi S, Alameddine M, et al. Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon. BMJ Open. 2019;9(3):e025074.
60. Faqi AS, Holm KA. Metabolism and Drug–Drug Interaction in Pregnant Mother/Placenta/Fetus. Dev Reprod Toxicol. Methods in Pharmacology and Toxicology2016. p. 1-16.
61. Ferracini AC, Rodrigues AT, Visacri MB, Stahlschmidt R, Silva N, Surita FG, et al. Potential Drug Interactions and Drug Risk during Pregnancy and Breastfeeding: An Observational Study in a Women’s Health Intensive Care Unit. Rev Bras Ginecol Obstet. 2017;39(6):258-64.
62. Rubinchik-Stern M, Eyal S. Drug Interactions at the Human Placenta: What is the Evidence? Front Pharmacol. 2012;3:126.